The Difference Between Learning Disabilities and ADHD

Bipolar disorder changes the weather inside a life. Mood swings disrupt work, sleep, relationships, and the sense that next month will look anything like this one. The emotional exhaustion of cycling through episodes and the strain those episodes put on close relationships are part of why so many patients describe bipolar disorder as harder to live with than almost any other condition they know. Medication is usually the foundation of treatment. But medication alone is rarely enough. Bipolar disorder supportive therapy is one of several psychotherapy approaches that sit alongside medication to turn stability into an actual life.

‍

This guide explains what supportive therapy is, how it fits alongside other therapies, and what kind of help may improve day-to-day stability.

What Is Supportive Therapy For Bipolar Disorder?

Supportive therapy is a psychotherapy approach built around emotional support, trust, validation, and practical coping. It does not focus on deep analysis of the unconscious, and it is not a structured skills protocol. It is the kind of therapy where a clinician listens carefully, helps you make sense of what you are feeling and going through, reinforces what is working, and helps you solve the next problem in front of you.

‍

Supportive therapy is almost always part of a broader treatment plan for bipolar disorder, not a replacement for psychiatric care. Most people combine it with medication management, and many eventually layer in more structured approaches like CBT or family-focused therapy.

What Techniques Are Used in Bipolar Disorder Supportive Therapy

The practical tools a supportive therapist uses include:

‍

• Emotional validation that acknowledges the real weight of what the person is experiencing
• Active listening that slows down and surfaces what is actually going on, not just the surface complaint
• Psychoeducation about the illness cycle, warning signs, and what to expect
• Problem-solving on concrete day-to-day stressors, from a difficult conversation to a medication side effect
• Strengthening insight about mood patterns and personal triggers
• Reinforcing engagement in the full treatment plan, including appointments and medication

How Supportive Therapy Helps People With Bipolar Disorder

Emotional Support During Mood Instability

Mood episodes are disorienting. A depressive stretch can last weeks, a hypomanic period can feel like the most productive month of your life until it crashes, and a mixed episode can fold both into the same week. Supportive therapy gives a person somewhere to bring that weight, week after week, with someone who understands what bipolar disorder looks like from the inside. That consistency alone steadies many patients through the worst stretches.

Building Coping Skills And Daily Stability

The practical work of staying well with bipolar disorder is mostly about routines. Supportive therapy helps people build and protect them:

‍

• Consistent sleep and wake times, because sleep disruption is a common trigger
• Strategies for stress management when life gets loud
• Conflict management skills for relationships under strain
• Recognizing early warning signs of an episode so they can be interrupted

Supporting Medication Adherence And Ongoing Care

Medication is the foundation of bipolar treatment. But it can also be hard to stay on. Side effects, the feeling of missing hypomanic energy, the belief that symptoms will not return, and plain forgetfulness all contribute to the high discontinuation rates that research keeps finding. Supportive therapy gives people a place to talk honestly about their fears and frustrations with medication, think through side effects with a trusted clinician, and stay engaged when the usual instinct would be to drop out.

Supportive Therapy vs. Other Therapy Approaches

Supportive therapy is one of several psychotherapy approaches with evidence for bipolar disorder. A quick comparison:

A large systematic review of 39 randomized trials of adjunctive psychotherapy for bipolar disorder found that family-focused, cognitive behavioral, and psychoeducational therapies reduced episode recurrence compared with usual treatment (Miklowitz et al., JAMA Psychiatry, 2021).

When Other Therapies May Be Added

Supportive therapy is often the right starting point, especially after a new diagnosis or during stabilization. Over time, many patients add a more structured approach:

‍

• CBT for persistent depressive symptoms or to build relapse-prevention skills
• DBT for patients with heavy emotional reactivity or co-occurring BPD features
• IPSRT for people whose episodes are tied to disrupted sleep and routines
• Family-focused therapy when relationship dynamics are shaping the illness course

‍

The choice depends on symptoms, goals, and what the person actually needs at that stage. A skilled clinician will adjust the approach as the picture changes.

What To Expect In Bipolar Disorder Supportive Therapy

Sessions are usually 45 to 50 minutes and are typically weekly at the start. The work is conversational rather than homework-driven. A session might open with what happened that week, look at mood patterns since the last visit, surface any new stressors, and end with a small plan for the week ahead.

‍

The clinician will pay attention to warning signs: sleep changes, energy shifts, spending or relationship patterns, and medication side effects. Over time, a person in supportive therapy often becomes much better at tracking their own mood, which makes the intervals between episodes longer and the episodes themselves shorter.

Who May Benefit Most

Supportive therapy tends to help most for:

‍

• People newly diagnosed who need to make sense of what bipolar disorder is and what the next year can look like
• People adjusting to treatment who are figuring out medication, routines, and how to communicate about the illness
• People navigating the emotional fallout of a recent episode, including shame, regret, or strain with family
• People in long-term stabilization who want a steady clinician presence without intensive protocols

‍

It is less of a match for patients who need heavy skills training for severe emotion dysregulation or those in active crisis, where higher levels of care are indicated.

When To Seek Professional Help For Bipolar Disorder

A few questions to ask yourself:

‍

• Are mood episodes interfering with work, school, or close relationships?
• Has your sleep pattern changed significantly for more than a week?
• Are you making impulsive decisions that later feel hard to explain?
• Is someone close to you saying your behavior feels out of character?
• Are you having thoughts of self-harm or suicide?

‍

If the answer to any of these is yes, it is worth calling a clinician. For immediate safety concerns, call 988 for the Suicide and Crisis Lifeline.

Bipolar Disorder Care At Amae Health

At Amae Health, we support individuals battling bipolar disorder. Our approach is integrated: psychiatrists, therapists, primary care providers, dietitians, health coaches, peer mentors, and clinical care coordinators all work from one shared treatment plan. That structure matters for bipolar disorder, because the condition touches sleep, physical health, medication, and relationships at the same time, and fragmented care usually misses something.

‍

If bipolar symptoms are disrupting daily life for you or someone you love, we can help with evaluation, treatment planning, and ongoing support. Learn more about our bipolar disorder care, read our guide to the most effective treatments for bipolar disorder, or call 1-888-860-2825 to start the conversation.

‍

Citations

1. Miklowitz et al., "Adjunctive Psychotherapy for Bipolar Disorder: A Systematic Review and Component Network Meta-analysis," JAMA Psychiatry, 2021. Tier 1 (peer-reviewed).

‍

Finishing a course of TMS and feeling like yourself again brings a new worry: will it hold? How long do TMS results last, and what happens if the depression comes back? The research is more encouraging than many people expect. Among people who respond to a course, roughly half to nearly two-thirds are still responding a year later, and when symptoms do return, restarting TMS brought back the improvement for most people in the research.

‍

None of that predicts any one person's course. It does show what tends to help results last, and why the months after treatment deserve a plan of their own.

What "Lasting" Means: Response vs. Remission

Two terms do most of the work in durability research. A person has responded when their depression scores fall by at least half on a standard rating scale. They're in remission when scores drop low enough that the depression is largely gone.

‍

Durability studies then ask a narrower question than the original trials did: of the people who responded or reached remission by the end of a course, how many were still doing well months later? That framing matters when you read the numbers. A result such as 62.5% of people keeping their response for a year describes people who had already responded, not everyone who started TMS. Those follow-up checks happen at set points, typically three, six, and 12 months after a course, so durability is reported as the share of people still responding at each checkpoint.

What the Research Shows About Durability

The most direct data come from a 2014 study in The Journal of Clinical Psychiatry that followed people with medication-resistant major depression for a year after they finished TMS at 42 U.S. clinical practices. Of the 257 people who completed a course and agreed to follow-up, 120 had responded or reached remission by the end of treatment. Of those 120, 75 (62.5%) kept meeting response criteria through the full 12 months.

‍

Two details shape that result. The study used a practical approach after the course: continued antidepressant medication, plus access to more TMS if symptoms returned. And over the year, 93 participants (36.2%) had TMS reintroduced at some point, averaging about 16 treatment days. So the 62.5% reflects TMS inside ongoing care, not a single course left to stand on its own.

‍

A 2019 meta-analysis in Brain Stimulation pooled 19 studies of people who had responded to a TMS course. About two-thirds were still responding at three months, about 53% at six months, and about 46% at one year. The authors' summary: roughly half of responders keep their response for up to a year after a successful course.

‍

Read together, the two studies give a realistic range of around half to nearly two-thirds of responders still doing well a year out. The other side of those numbers matters just as much. A meaningful share of people see symptoms return within the first year, and planning for that possibility is part of good care, not a sign that treatment failed.

Factors That Influence How Long Results Last

The research has identified a few patterns, mostly at the level of groups rather than individuals:

‍

• Maintenance treatment. In the 2019 meta-analysis, studies that included maintenance treatment showed higher sustained response at some time points.
• The mix of people studied. Studies with a higher proportion of women also showed higher sustained response, a group-level pattern that says nothing reliable about any one person.
• Continued medication. The best-known durability results come from people who stayed on antidepressants after TMS, so those numbers describe that combination.
• A completed course. Durability figures come from people who finished a full acute course. They don't describe what happens after a partial one.

‍

Clinicians also weigh a person's history when planning follow-up, such as how many depressive episodes they've had and how many treatments failed before TMS. The findings above don't establish how much those factors change the odds, so they inform a clinician's judgment rather than supply a number.

Maintenance TMS: What It Is and Who May Need It

TMS maintenance treatment means periodic sessions after the main course, scheduled to protect a response rather than to answer a relapse. Schedules vary between providers and between people, and no single schedule has become standard.

‍

The evidence supports the idea without settling the details. The 2019 meta-analysis found maintenance associated with more durable response, and its authors suggested maintenance be considered in practice and tested in future trials. That's a promising signal, not a proven protocol. Maintenance TMS is also separate from staying on medication: in both the year-long and six-month studies, people continued antidepressants whether or not they received more TMS.

‍

Not everyone needs it. Some people stay well for long stretches without it. Whether maintenance makes sense for a particular person is a judgment a psychiatrist makes from their history and how they're doing in the months after the course.

Can TMS Be Repeated If Symptoms Return?

Yes, and the research on restarting TMS is among the most reassuring parts of this topic. In a six-month study in Brain Stimulation, people whose depression had improved by at least a quarter with TMS stopped treatment gradually over three weeks while starting maintenance antidepressant medication. In that study, worsening had a specific meaning: a clinician-rated decline that held for two consecutive weeks, which triggered restarting TMS. Over the next 24 weeks, 38% had symptoms worsen enough to restart TMS, and 32 of those 38 people (84%) regained their improvement. Only 10% of the 99 people whose results were reported met the study's definition of relapse.

‍

A repeat course is different from maintenance. Maintenance is planned in advance to hold a response; a repeat course starts because symptoms have come back. In the year-long study described above, about a third of participants had TMS reintroduced at some point. Whether and when to restart is a decision made with a psychiatrist, based on how symptoms are changing.

What Helps Results Last Longer

Beyond maintenance and continued medication, two more things help, though neither promises that results will last for a particular person:

‍

• Catching changes early. In the six-month study, regular assessments flagged worsening symptoms, and most people who restarted TMS at that point regained their improvement.
• Staying connected to care. Therapy and regular psychiatric visits mean someone is watching for early changes between treatments.

‍

Knowing what returning depression tends to look like makes early changes easier to catch: shifts in sleep or appetite, lower energy, less interest in usual activities, and a low mood that lingers instead of lifting after a few days. When those signs show up, reaching out sooner gives a care team more options, and our guide on how to ask for help when depressed covers how to start that conversation.

‍

These describe what research associates with better long-term results in groups of patients. They aren't instructions for any one person's treatment plan; that's a psychiatrist's call, made with the whole history in view.

Talking to a Psychiatrist About a Long-Term Plan

A TMS course is the start of a plan, not the end of one. The months afterward are when follow-up, medication decisions, and a clear plan for what happens if symptoms return matter most.

‍

At Amae, TMS sits inside our integrated care model, where psychiatric care, therapy, primary care, and peer support stay linked after the course ends. We provide TMS therapy for major depressive disorder at our Los Angeles clinic and at our Bay Area clinics in Los Altos and San Mateo. Commercial insurance plans and cash pay are both accepted, and our intake team handles prior authorization. To map out what comes after a course, talk with an Amae psychiatrist about a long-term plan. Anyone in crisis can reach the 988 Suicide and Crisis Lifeline by call or text.

Frequently Asked Questions

How long do TMS results typically last?

For many people, months to a year or longer, though it varies. In a year-long study of people who responded to TMS, 62.5% kept meeting response criteria for the full 12 months. A 2019 meta-analysis found that about half of responders were still responding at one year.

What percentage of people relapse after TMS?

Some return of symptoms within a year is common. In the 2019 meta-analysis, roughly half of responders were no longer responding at one year. That isn't always a full relapse: in a six-month study, 38% had symptoms worsen enough to restart TMS, while 10% met the study's definition of relapse.

Can TMS be repeated if depression comes back?

Yes. In a six-month study, 84% of people whose symptoms worsened regained their improvement when TMS was restarted. A repeat course is different from ongoing maintenance sessions, and the decision is made with a psychiatrist based on individual history.

Do I need maintenance TMS sessions after my initial course?

Not necessarily. Some people stay well without them, and there is no standard maintenance schedule across providers. Research links maintenance with longer-lasting response, so whether it fits is a decision a psychiatrist makes based on your response and how closely symptoms are being monitored.

What can help TMS results last longer?

The research points to planned follow-up, continued medication when it's part of the plan, and catching symptom changes early. These are general findings from groups of patients, not instructions for any one person's treatment.

Is maintenance TMS covered by insurance?

It depends on the insurer and on whether sessions are billed as maintenance or as a new course for returning symptoms, since coverage can differ between the two. Ask the provider to verify benefits with your insurer before sessions begin.

‍

Citations

1. Dunner DL, Aaronson ST, Sackeim HA, et al. A multisite, naturalistic, observational study of transcranial magnetic stimulation for patients with pharmacoresistant major depressive disorder: durability of benefit over a 1-year follow-up period. Journal of Clinical Psychiatry. 2014;75(12):1394-1401. https://pubmed.ncbi.nlm.nih.gov/25271871/
2. Senova S, Cotovio G, Pascual-Leone A, Oliveira-Maia AJ. Durability of antidepressant response to repetitive transcranial magnetic stimulation: systematic review and meta-analysis. Brain Stimulation. 2019;12(1):119-128. https://pubmed.ncbi.nlm.nih.gov/30344109/
3. Janicak PG, Nahas Z, Lisanby SH, et al. Durability of clinical benefit with transcranial magnetic stimulation (TMS) in the treatment of pharmacoresistant major depression: assessment of relapse during a 6-month, multisite, open-label study. Brain Stimulation. 2010;3(4):187-199. https://pubmed.ncbi.nlm.nih.gov/20965447/
4. 988 Suicide and Crisis Lifeline. https://988lifeline.org

‍

Most people comparing TMS vs medication for depression arrive at the question the same way: the antidepressants have not brought enough relief. If that is you, it helps to know that both are evidence-based, FDA-cleared treatments, and they work in completely different ways. Medication adjusts brain chemistry from the inside. TMS stimulates the brain directly with magnetic pulses. Neither is universally better. The right choice depends on your treatment history, the severity of your symptoms, how you tolerate side effects, and your own preferences, especially once you are dealing with treatment-resistant depression or trying to figure out what to do when antidepressants don't work. This article compares the two fairly, not to push one over the other.

How Antidepressants Work

Antidepressants change the availability of certain brain chemicals, mainly serotonin and norepinephrine, that influence mood. The most common are SSRIs (selective serotonin reuptake inhibitors) and SNRIs (serotonin-norepinephrine reuptake inhibitors). Both are considered first-line treatment, meaning they are usually where a clinician starts.

‍

They are taken daily as a pill at home, and they work gradually. Most people need several weeks before the full effect shows, which is one of the harder parts of starting an antidepressant: you often have to wait to know whether it is working. Finding the right medication and dose regularly takes some trial and adjustment, and a first medication that does not help does not mean none will. There are many options within each class, so a clinician can switch or fine-tune based on how a person responds. Older tricyclic antidepressants (TCAs) also work but tend to cause harsher side effects, so they are usually reserved for later steps rather than first-line use. The main appeal of medication is convenience and evidence: it is taken at home, it is inexpensive, and it has decades of research behind it.

How TMS Works

Transcranial magnetic stimulation (TMS) is a non-invasive treatment that uses focused magnetic pulses, similar in strength to an MRI, to stimulate the mood-regulating areas of the brain that tend to be underactive in depression, mainly the left dorsolateral prefrontal cortex. It is FDA-cleared for major depressive disorder in adults, and also for OCD (NIMH, Brain Stimulation Therapies).

‍

TMS is not electroconvulsive therapy (ECT). There is no anesthesia and no sedation, and the patient stays fully awake through each session, then drives home and returns to normal activity. During a session, a coil rests against the scalp and delivers pulses in short cycles, which most people feel as a tapping sensation. A typical course runs about five days a week for several weeks, with each session lasting under an hour, and the benefit tends to build gradually across the course rather than after any single visit.

‍

As a non-drug option, TMS is one of the main alternatives to antidepressants for people whose medication has stopped short. It usually works best as part of a broader treatment plan, coordinated with therapy and, in many cases, ongoing medication, rather than as a replacement for all other care.

TMS vs Medication: Side-by-Side Comparison

The two treatments differ on almost every practical dimension, from how they are delivered to how quickly they work and what they ask of you day to day. The table below lays the key differences side by side, and the sections that follow unpack the two that matter most to people making this decision: side effects and success rates.

Side Effects Compared

Antidepressant side effects vary by class. SSRIs commonly cause weight gain and sexual dysfunction, though some effects ease after the first few weeks. SNRIs have a similar profile that is often milder. TCAs tend to be harsher, which is why they are rarely a first choice. These are systemic effects, because the medication acts throughout the body.

‍

TMS side effects are usually mild and short-lived: scalp discomfort, headache, or lightheadedness that typically passes soon after a session and lessens over the first week. The most serious risk, seizure, is very rare. Because TMS is non-invasive and targeted rather than systemic, it avoids the weight, sexual, and sleep side effects associated with medication, and it does not affect memory or cognition the way some people fear based on older brain treatments like ECT.

‍

It is not side-effect-free, though, and its main practical downside is different in kind. Instead of a daily side effect, TMS asks for a time commitment: traveling to a clinic most weekdays for several weeks. For someone with a demanding schedule or limited transportation, that logistical cost is real and worth weighing against the appeal of avoiding medication side effects. Neither profile is automatically easier to live with; they are simply different, and which one fits depends on the person.

Success Rates: What the Research Shows

Both treatments help many people, and neither helps everyone. Reading the numbers honestly matters more than cheerleading for either one. Two terms come up often: response means a meaningful reduction in symptoms, usually cutting them roughly in half, while remission means symptoms largely resolve. Remission is the higher bar and the real goal.

‍

For medication, the landmark STAR*D study found that roughly a third of patients reached remission on their first SSRI (Trivedi et al., American Journal of Psychiatry, 2006). That is a genuinely useful result for many people. But it also means most did not remit on the first try, and STAR*D showed that with each additional medication tried after a failure, the odds of remission tend to drop while side-effect burden tends to rise. That diminishing return is exactly the situation that leads people to look at other options.

‍

For TMS, a large real-world registry of more than 5,000 patients found that most experienced measurable improvement, with response rates ranging from about 58% to 83% and remission from about 28% to 62%, depending on how outcomes were measured (Sackeim et al., Journal of Affective Disorders, 2020). The wide ranges are worth noting: they reflect different rating scales and patient groups, and many of those patients were also taking medication, so the numbers describe TMS in real-world use rather than in isolation.

‍

For treatment-resistant depression specifically, a 2024 randomized trial compared TMS with switching or augmenting medication in 89 people who had not responded to at least two antidepressants, with both groups also receiving psychotherapy. The TMS group had significantly higher response and remission rates than the medication group (Dalhuisen et al., American Journal of Psychiatry, 2024). It is one of the clearest head-to-head comparisons available, though individual results always vary, and these figures describe groups, not guarantees for any one person.

When Antidepressants Don't Work: Where TMS Fits

About a third of people with major depressive disorder do not respond adequately to first-line treatment, a pattern clinicians call treatment-resistant depression. It is not a sign of personal failure or a rare edge case; it is common, and it has its own growing set of treatment options. When two or more medications have failed, or when side effects are intolerable, TMS becomes a well-supported next step, and the 2024 trial above is part of why it is increasingly positioned early in the treatment-resistant pathway rather than as a last resort.

‍

TMS is not the only option at this stage. Spravato (esketamine), a nasal spray derived from ketamine, is FDA-approved for treatment-resistant depression when used together with an oral antidepressant. It is given in a certified clinic under medical supervision, with monitoring after each dose, because of its dissociative effects. Combining TMS with an antidepressant is another route, and research suggests the combination can improve outcomes over medication alone. The larger point is that once first-line medication falls short, the path forward branches into several evidence-based options, and those branches are not mutually exclusive. A person might use medication and TMS together, or move from one approach to another as their psychiatrist learns what their brain responds to.

Who Is Each Treatment For?

Medication is often the right starting point for someone who is:

‍

• Early in treatment for depression
• Managing mild to moderate symptoms
• Looking to avoid in-clinic visits
• Someone who has responded well to an antidepressant before

‍

TMS is generally considered for someone who:

‍

• Has tried multiple antidepressants without adequate relief
• Cannot tolerate medication side effects
• Prefers a non-drug approach
• Has treatment-resistant depression

‍

Many people use both at different points, and some use them together. Where a person lands is a clinical decision, not a solo consumer choice, and it belongs with a psychiatrist who knows the full history.

Making the Decision With a Psychiatrist

TMS, medication, Spravato, and therapy are not competing products. They are tools a psychiatrist combines and adjusts based on diagnosis, history, and how a person responds over time. Comparing TMS and medication on paper is useful, but the decision is rarely either-or, and it is rarely one-and-done. It usually looks more like a sequence: start somewhere reasonable, measure the response, and adjust. The most reliable way to navigate that sequence, and to change course when needed, is a thorough evaluation within an integrated care setting, where the clinician managing your medication is the same one weighing whether TMS or another option fits.

‍

That is how care works at Amae Health. Our psychiatry-led teams evaluate the whole picture and coordinate treatment across medication, therapy, and procedures like TMS, which we offer at our Los Angeles clinic. You can explore our full range of treatments or, for severe depression that needs more structure, our Partial Hospitalization Program. Our resources for patients and families explain how integrated care works, and you can contact our team to ask about an evaluation.

Frequently Asked Questions

Is TMS better than medication for depression? Neither is universally better. Medication is first-line and works well for many people. For treatment-resistant depression, where two or more medications have failed, TMS often outperforms a medication switch. The right choice depends on history, severity, and side-effect tolerance.

‍

Can you do TMS and take antidepressants at the same time? Yes. TMS can be combined with antidepressants, and research suggests the combination can improve outcomes compared with medication alone. This should be coordinated by a psychiatrist.

‍

What are the side effects of TMS vs medication? TMS side effects are usually mild and short-lived, mainly scalp discomfort or headache that fades after the first week. Medication side effects vary but can include weight change, sexual dysfunction, and fatigue. Because it is non-invasive, TMS avoids the systemic side effects of medication.

‍

Does TMS work when antidepressants don't? Often, yes. TMS is specifically supported for treatment-resistant depression. A 2024 randomized trial found higher response and remission rates with TMS than with switching medications after failed trials. Individual results vary.

‍

How long does TMS treatment take? A typical course is sessions about five days a week for several weeks, each lasting under an hour. Antidepressants, by contrast, are taken daily and may take several weeks to show their full effect.

‍

What if neither TMS nor medication works? Other options exist, including Spravato (esketamine) used with an oral antidepressant, combination approaches, and structured programs like IOP or PHP for severe depression. A psychiatrist can help identify next steps. Depression is hard, and support is available: if you are struggling, call or text the 988 Suicide and Crisis Lifeline at 988, anytime.

‍

Citations

1. Trivedi MH, Rush AJ, Wisniewski SR, et al. "Evaluation of Outcomes With Citalopram for Depression Using Measurement-Based Care in STAR*D." American Journal of Psychiatry, 2006. psychiatryonline.org. Tier 1 (peer-reviewed).
2. Sackeim HA, Aaronson ST, Carpenter LL, et al. "Clinical outcomes in a large registry of patients with major depressive disorder treated with transcranial magnetic stimulation." Journal of Affective Disorders, 2020. sciencedirect.com. Tier 1 (peer-reviewed).
3. Dalhuisen I, van Oostrom I, Spijker J, et al. "rTMS as a Next Step in Antidepressant Nonresponders: A Randomized Comparison With Current Antidepressant Treatment Approaches." American Journal of Psychiatry, 2024. PubMed 39108161. Tier 1 (peer-reviewed RCT).
4. National Institute of Mental Health, "Brain Stimulation Therapies." nimh.nih.gov. Tier 2 (U.S. government).

‍

Further reading (external resources): NIMH, Depression; Mayo Clinic, Transcranial Magnetic Stimulation.

‍